Legislative subject term
Drug safety, medical device, and laboratory regulation
A legislative subject term is one of any number the Congressional Research Service assigns to a bill. The term is the government's own wording, shown word for word; this site did not write it or choose it.
194 bills carry this term in the covered Congresses.
Follow this topic by feed — new official actions on these bills, no account needed.
Bills, most recent action first
-
Combating Illicit Xylazine Act
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
-
Nitrous Oxide Safety Act of 2026
Ordered to be Reported by the Yeas and Nays: 36 - 0.
-
INSULIN Act of 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
-
Medication Affordability and Patent Integrity Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 528.
-
Expedited Access to Biosimilars Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.
-
Biosimilar Red Tape Elimination Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
-
Patients Deserve Price Tags Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 522.
-
SAFE Drugs Act of 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 524.
- H.R. 9770 (119th) Jul 22, 2026
Making continuing appropriations for fiscal year 2027, and for other purposes.
Received in the Senate.
-
FDA Modernization Act 3.0
Received in the Senate.
-
SCALE Biology Act
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
-
Affordable Prescriptions for Patients Act
Held at the desk.
-
Health Care Price Certainty for All Americans Act
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 25 - 15.
-
Carla Walker Act
Held at the desk.
-
VA National Formulary Act of 2025
Committee Hearings Held
-
Veterans Health Administration Novel Therapeutics Preparedness Act
Committee on Veterans' Affairs. Hearings held.
-
Combating Illicit Xylazine Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
- H.R. 7148 (119th) Feb 3, 2026
Consolidated Appropriations Act, 2026
Became Public Law No: 119-75.
- S. 1071 (119th) Dec 18, 2025
National Defense Authorization Act for Fiscal Year 2026
Became Public Law No: 119-60.
-
FDA Modernization Act 3.0
Held at the desk.
-
SAFE Drugs Act of 2025
Referred to the House Committee on Energy and Commerce.
-
Mikaela Naylon Give Kids a Chance Act
Received in the Senate.
- H.R. 5371 (119th) Nov 12, 2025
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Became Public Law No: 119-37.
- S. 2296 (119th) Nov 12, 2025
National Defense Authorization Act for Fiscal Year 2026
Held at the desk.
-
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- S. 2882 (119th) Oct 9, 2025
Continuing Appropriations and Extensions and Other Matters Act, 2026
Motion by Senator Schumer to reconsider, under the order of 10/9/2025, not having voted on the prevailing side, the vote by which the third cloture motion on the motion to proceed to S. 2882 was not invoked (Record Vote No. 557) entered in Senate.
- H.R. 3838 (119th) Sep 30, 2025
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Received in the Senate.
-
Patients Deserve Price Tags Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Biosimilar Red Tape Elimination Act
Referred to the House Committee on Energy and Commerce.
-
Continuing Appropriations and Extensions and Other Matters Act, 2026
Referred to the Committee on Appropriations, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Over-the-Counter Monograph Drug User Fee Amendments
Placed on the Union Calendar, Calendar No. 254.
-
Ensuring Patient Access to Critical Breakthrough Products Act
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
-
Newborn Screening Saves Lives Reauthorization Act of 2025
Forwarded by Subcommittee to Full Committee by Voice Vote.
-
Over-the-Counter Monograph Drug User Fee Amendments
Placed on Senate Legislative Calendar under General Orders. Calendar No. 152.
-
Intelligence Authorization Act for Fiscal Year 2026
By Senator Cotton from Select Committee on Intelligence filed written report. Report No. 119-51. Minority views filed.
-
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 112.
-
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Placed on the Union Calendar, Calendar No. 138.
-
Carla Walker Act
Referred to the House Committee on the Judiciary.
-
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Referred to the House Committee on Energy and Commerce.
-
Drug Competition Enhancement Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 43.
-
Stop STALLING Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.
-
Interagency Patent Coordination and Improvement Act of 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
- H.R. 1968 (119th) Mar 15, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Became Public Law No: 119-4.
-
DHS Biodetection Improvement Act
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
-
Scientific EXPERT Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
CUTS Act
Referred to the Subcommittee on Highways and Transit.
-
Humane Cosmetics Act of 2025
Referred to the House Committee on Energy and Commerce.
-
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Innovation in Pediatric Drugs Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)
-
Protecting Life from Chemical Abortions Act
Referred to the House Committee on Energy and Commerce.
-
Scientific EXPERT Act of 2025
Referred to the House Committee on Energy and Commerce.
-
Medical Device Electronic Labeling Act
Referred to the House Committee on Energy and Commerce.
-
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
Referred to the House Committee on Energy and Commerce.
-
Safe and Affordable Drugs from Canada Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Responsibility in Drug Advertising Act of 2025
Referred to the House Committee on Energy and Commerce.
-
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Referred to the House Committee on Energy and Commerce.
-
Modern Authentication of Pharmaceuticals Act of 2025
Referred to the House Committee on Energy and Commerce.
-
Responsibility in Drug Advertising Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Saving Seniors Money on Prescriptions Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Prompt Approval of Safe Generic Drugs Act
Referred to the House Committee on Energy and Commerce.
-
Pregnancy Is Not an Illness Act of 2025
Referred to the House Committee on Energy and Commerce.
-
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Referred to the House Committee on Energy and Commerce.
-
SAVE Moms and Babies Act of 2025
Referred to the House Committee on Energy and Commerce.
- H.R. 3391 (118th) Jan 4, 2025
Gabriella Miller Kids First Research Act 2.0
Became Public Law No: 118-228.
-
Inflation Reduction Act of 2025
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, Agriculture, Natural Resources, Financial Services, Science, Space, and Technology, Transportation and Infrastructure, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Prescription Freedom Act of 2025
Referred to the House Committee on Energy and Commerce.
-
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Placed on the Union Calendar, Calendar No. 801.
- H.R. 5009 (118th) Dec 23, 2024
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Became Public Law No: 118-159.
- H.R. 10545 (118th) Dec 21, 2024
American Relief Act, 2025
Became Public Law No: 118-158.
-
Preserving Telehealth, Hospital, and Ambulance Access Act
Placed on the Union Calendar, Calendar No. 786.
-
Saving Access to Laboratory Services Act
Referred to the Subcommittee on Trade.
-
Expanding Care in the Home Act
Referred to the Subcommittee on Work and Welfare.
-
Fairness for Patient Medications Act
Referred to the Subcommittee on Health.
-
Medicare for All Act
Referred to the Subcommittee on Health.
-
Affordability is Access Act of 2023
Referred to the Subcommittee on Health.
-
Rural Health Clinic Burden Reduction Act
Referred to the Subcommittee on Health.
-
Clinical Laboratory Price Transparency Act of 2023
Referred to the Subcommittee on Health.
-
Medicare PBM Accountability Act
Referred to the Subcommittee on Health.
-
Joe Fiandra Access to Home Infusion Act of 2023
Referred to the Subcommittee on Health.
-
Safe Medicine Act
Referred to the Subcommittee on Health.
-
Bipartisan Keep America Open Act
Referred to the Subcommittee on Work and Welfare.
-
States Reform Act of 2023
Referred to the Subcommittee on Trade.
-
Further Strengthening America’s Supply Chain and National Security Act
Referred to the Subcommittee on Trade.
-
COOL Online Act
Referred to the Subcommittee on Trade.
-
To amend title XVIII of the Social Security Act with respect to the work geographic index for physician payments under the Medicare program, and to revise the phase-in of clinical laboratory test payment changes under such program.
Referred to the Subcommittee on Health.
-
FDA Modernization Act 3.0
Held at the desk.
-
Carla Walker Act
Referred to the House Committee on the Judiciary.
-
Carla Walker Act
Read twice and referred to the Committee on the Judiciary.
-
DHS Biodetection Improvement Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
-
Scientific EXPERT Act of 2024
Referred to the House Committee on Energy and Commerce.
- H.R. 9747 (118th) Sep 26, 2024
Continuing Appropriations and Extensions Act, 2025
Became Public Law No: 118-83.
-
Give Kids a Chance Act of 2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- H.R. 9494 (118th) Sep 18, 2024
Continuing Appropriations and Other Matters Act, 2025
Motion to reconsider laid on the table Agreed to without objection.
-
Prompt Approval of Safe Generic Drugs Act
Referred to the House Committee on Energy and Commerce.
-
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
Placed on the Union Calendar, Calendar No. 544.
-
Innovation in Pediatric Drugs Act of 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
-
Safe and Affordable Drugs from Canada Act of 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Responsibility in Drug Advertising Act of 2024
Referred to the House Committee on Energy and Commerce.
-
Responsibility in Drug Advertising Act of 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Affordable Prescriptions for Patients Act of 2023
Held at the desk.
-
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Placed on the Union Calendar, Calendar No. 483.
-
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 437.
-
CUTS Act
Referred to the Committee on Oversight and Accountability, and in addition to the Committees on Appropriations, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Creating Hope Reauthorization Act of 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- H.R. 4366 (118th) Mar 9, 2024
Consolidated Appropriations Act, 2024
Became Public Law No: 118-42.
- H.Res. 1061 (118th) Mar 6, 2024
Providing for the concurrence by the House in the Senate amendment to H.R. 4366, with an amendment.
Motion to reconsider laid on the table Agreed to without objection.
- H.R. 7463 (118th) Mar 1, 2024
Extension of Continuing Appropriations and Other Matters Act, 2024
Became Public Law No: 118-40.
-
Creating Hope Reauthorization Act of 2024
Referred to the Subcommittee on Health.
-
FDA Modernization Act 3.0
Referred to the Subcommittee on Health.
-
SUPPORT for Patients and Communities Reauthorization Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 319.
- H.R. 2872 (118th) Jan 19, 2024
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Became Public Law No: 118-35.
-
Effective Screening and Testing for Tuberculosis Act
Referred to the Subcommittee on Health.
-
RAPID Reserve Act
Referred to the Subcommittee on Health.
-
Nuclear Medicine Clarification Act of 2023
Referred to the Subcommittee on Energy, Climate and Grid Security.
- H.R. 4531 (118th) Dec 13, 2023
Support for Patients and Communities Reauthorization Act
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
COOL Online Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 289.
-
Pregnancy Is Not an Illness Act of 2023
Sponsor introductory remarks on measure. (CR H6825)
-
STATES 2.0 Act
Referred to the Subcommittee on Highways and Transit.
-
Innovation in Pediatric Drugs Act of 2023
Referred to the Subcommittee on Health.
-
Modernizing and Ensuring PBM Accountability Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 266.
-
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 265.
-
Veterans HOPE Act
Referred to the Subcommittee on Health.
- H.R. 6363 (118th) Nov 17, 2023
Further Continuing Appropriations and Other Extensions Act, 2024
Became Public Law No: 118-22.
- H.R. 5894 (118th) Nov 15, 2023
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
POSTPONED PROCEEDINGS - Pursuant to clause 1(c) of rule XIX, the Chair announced further proceedings on H.R. 5894 would be postponed.
-
Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023
Referred to the Subcommittee on Health.
-
Protecting Consumer Access to Generic Drugs Act of 2023
Referred to the Subcommittee on Innovation, Data, and Commerce.
-
Influenza Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Further Strengthening America’s Supply Chain and National Security Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Federal Kratom Consumer Protection Act
Referred to the House Committee on Energy and Commerce.
-
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Referred to the Subcommittee on Health.
-
To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for mifepristone, and for other purposes.
Referred to the Subcommittee on Health.
-
Federal Kratom Consumer Protection Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- H.R. 5860 (118th) Sep 30, 2023
Continuing Appropriations Act, 2024 and Other Extensions Act
Became Public Law No: 118-15.
-
Health Care Price Transparency Act of 2023
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-231, Part I.
- H.R. 4368 (118th) Sep 28, 2023
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
Motion to reconsider laid on the table Agreed to without objection.
-
Give Kids a Chance Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Humane Cosmetics Act of 2023
Referred to the Subcommittee on Health.
-
Medication Affordability and Patent Integrity Act
Referred to the Subcommittee on Health.
-
Pandemic and All-Hazards Preparedness and Response Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 202.
-
IMPROVE Addiction Care Act
Referred to the Subcommittee on Health.
-
Modern Authentication of Pharmaceuticals Act of 2023
Referred to the Subcommittee on Health.
-
RAPID Reserve Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
IMPROVE Addiction Care Act
Read twice and referred to the Committee on Finance.
-
Increasing Prescription Drug Competition Act
Referred to the Subcommittee on Health.
-
Protecting PAHPA Act of 2023
Referred to the Subcommittee on Health.
-
Securing Gene Synthesis Act
Referred to the Subcommittee on Health.
-
SWIFT Detection Act of 2023
Referred to the Subcommittee on Health.
-
Preparing for All Hazards and Pathogens Reauthorization Act
Ordered to be Reported (Amended) by the Yeas and Nays: 28 - 23.
-
Securing Gene Synthesis Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
OTC Act of 2023
Referred to the Subcommittee on Health.
-
Medicare PBM Accountability Act
Read twice and referred to the Committee on Finance.
-
Promising Pathway Act
Referred to the Subcommittee on Health.
-
ADINA Act
Referred to the Subcommittee on Health.
-
Protect Our Civil Liberties Act
Referred to the Subcommittee on Health.
-
Ensuring Timely Access to Generics Act of 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 107.
-
Expanding Access to Low-Cost Generics Act of 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.
-
RARE Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 109.
-
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
Placed on Senate Legislative Calendar under General Orders. Calendar No. 111.
-
ADINA Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
FIND Fentanyl Act of 2023
Referred to the Subcommittee on Health.
-
United States-Israel Health Technologies Cooperation Act
Referred to the Subcommittee on Health.
-
Updated Drug Labeling for Patient Safety Act
Referred to the Subcommittee on Health.
-
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Referred to the Subcommittee on Health.
-
Promising Pathway Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Cosmetic Supply Chain Transparency Act of 2023
Referred to the Subcommittee on Health.
-
Recall Unsafe Drugs Act of 2023
Referred to the Subcommittee on Health.
-
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023
Referred to the Subcommittee on Health.
-
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection.
Referred to the Subcommittee on Health.
-
Saving Access to Laboratory Services Act
Referred to the Subcommittee on Health.
-
Saving Access to Laboratory Services Act
Read twice and referred to the Committee on Finance.
-
TRACK Act of 2023
Referred to the Subcommittee on Oversight and Investigations.
-
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023
Referred to the Subcommittee on Health.
-
Increasing Transparency in Generic Drug Applications Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Stop STALLING Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 21.
-
Increasing Prescription Drug Competition Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Interagency Patent Coordination and Improvement Act of 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
-
CCM–CARE Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Ensuring Women’s Right to Reproductive Freedom Act
Referred to the Subcommittee on Health.
-
TRACK Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Inflation Reduction Act of 2023
Referred to the Subcommittee on Highways and Transit.
-
Rural Health Clinic Burden Reduction Act
Read twice and referred to the Committee on Finance.
-
Parental Rights Protection Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
No Vaccine Passports Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Referred to the Subcommittee on Health.
-
Protecting Life from Chemical Abortions Act
Referred to the Subcommittee on Health.
-
SAVE Moms and Babies Act of 2023
Referred to the Subcommittee on Health.
-
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
SAVE Moms and Babies Act of 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
MMEDS Act of 2023
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
MMEDS Act of 2023
Read twice and referred to the Committee on Finance.
-
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
Referred to the Subcommittee on Health.
-
Medical Innovation Acceleration Act of 2023
Referred to the House Committee on Energy and Commerce.
-
Prescription Freedom Act of 2023
Referred to the House Committee on Energy and Commerce.
A bill gets a page here once it reaches a recorded vote; until then its official record on congress.gov is the link. Every bill in the covered Congresses is tracked either way.